Cargando…
Novel contributors to B cell activation during inflammatory CNS demyelination; An oNGOing process
Over the past two decades, the development of targeted immunotherapeutics for relapsing-remitting multiple sclerosis has been successfully orchestrated through the efficacious modulation of neuroinflammatory outcomes demonstrated in the experimental autoimmune encephalomyelitis (EAE) model. In this...
Autores principales: | Damianidou, Olympia, Theotokis, Paschalis, Grigoriadis, Nikolaos, Petratos, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692119/ https://www.ncbi.nlm.nih.gov/pubmed/34975310 http://dx.doi.org/10.7150/ijms.66350 |
Ejemplares similares
-
Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2021) -
How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
por: Rashidbenam, Zahra, et al.
Publicado: (2023) -
CNS Ageing in Health and Neurodegenerative Disorders
por: Kesidou, Evangelia, et al.
Publicado: (2023) -
Developmental Cues and Molecular Drivers in Myelinogenesis: Revisiting Early Life to Re-Evaluate the Integrity of CNS Myelin
por: Dermitzakis, Iasonas, et al.
Publicado: (2022) -
Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
por: Kim, Min Joung, et al.
Publicado: (2018)